We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAN
2451
DELISTED
GAN Ltd
GAN
| $123K | ﹤0.01% |
95,457
+25,657
| +37% | +$46.7K |
|
2452
CALL
Applied Materials
AMAT
$347B
| $123K | ﹤0.01% |
1,000
-17,100
| -94% | -$1.96M |
|
2453
Emergent Biosolutions
EBS
$379M
| $123K | ﹤0.01% |
+11,832
| New | +$143K |
|
2454
Pixelworks
PXLW
$37.2M
| $122K | ﹤0.01% |
+6,893
| New | +$145K |
|
|
SUPV
2455
Grupo Supervielle
SUPV
$823M
| $122K | ﹤0.01% |
54,163
+40,259
| +290% | +$104K |
|
2456
Daktronics
DAKT
$946M
| $121K | ﹤0.01% |
+21,292
| New | +$86.9K |
|
2457
Gaotu Techedu
GOTU
$405M
| $116K | ﹤0.01% |
27,600
-33,521
| -55% | -$131K |
|
|
ORGN
2458
DELISTED
Origin Materials
ORGN
| $115K | ﹤0.01% |
+894
| New | +$132K |
|
2459
Paysign
PAYS
$517M
| $114K | ﹤0.01% |
+31,380
| New | +$107K |
|
2460
Traeger
COOK
$165M
| $114K | ﹤0.01% |
554
-4,564
| -89% | -$817K |
|
|
CIFRW
2461
CALL
DELISTED
Cipher Mining Warrant
CIFRW
| $114K | ﹤0.01% |
48,720
| – | – |
|
2462
Adicet Bio
ACET
$77.6M
| $113K | ﹤0.01% |
+1,223
| New | +$153K |
|
2463
Omeros
OMER
$845M
| $113K | ﹤0.01% |
24,206
-55,966
| -70% | -$202K |
|
|
NOTV
2464
DELISTED
Inotiv
NOTV
| $111K | ﹤0.01% |
25,700
+12,193
| +90% | +$77.6K |
|
|
CIO
2465
DELISTED
City Office REIT
CIO
| $111K | ﹤0.01% |
16,070
-134,429
| -89% | -$1.14M |
|
2466
Korea Electric Power
KEP
$14.6B
| $108K | ﹤0.01% |
+15,541
| New | +$115K |
|
2467
LSB Industries
LXU
$824M
| $106K | ﹤0.01% |
10,272
-115,390
| -92% | -$1.41M |
|
|
ROVR
2468
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $101K | ﹤0.01% |
22,333
-249,905
| -92% | -$1.01M |
|
|
LENZ
2469
LENZ Therapeutics
LENZ
$179M
| $100K | ﹤0.01% |
+5,844
| New | +$94.5K |
|
2470
Lindblad Expeditions
LIND
$1.95B
| $99.4K | ﹤0.01% |
10,400
-88,469
| -89% | -$890K |
|
2471
BlackSky Technology
BKSY
$843M
| $98.6K | ﹤0.01% |
8,220
-2,125
| -21% | -$28.7K |
|
2472
eGain
EGAN
$186M
| $96.4K | ﹤0.01% |
+12,700
| New | +$109K |
|
2473
Aligos Therapeutics
ALGS
$26.3M
| $94.5K | ﹤0.01% |
+4,344
| New | +$166K |
|
2474
Kopin
KOPN
$586M
| $94.1K | ﹤0.01% |
86,303
-37,500
| -30% | -$45.8K |
|
2475
Spero Therapeutics
SPRO
$68.9M
| $93.4K | ﹤0.01% |
64,388
+13,471
| +26% | +$22.6K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.